A commentary on 'Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: a meta-analysis'.
作者信息
Liu Xiuli, Song Linru, Wang Yuanyuan, Li Yanqiu
机构信息
Department of Pulmonary and Critical Care Medicine, Yantai Yuhuangding Hospital.
Department of Respiratory Intensive Care Unit, Yantai Yuhuangding Hospital, Yantai, Shandong, People's Republic of China.
出版信息
Int J Surg. 2024 Aug 1;110(8):5155-5156. doi: 10.1097/JS9.0000000000001448.
Abstract
摘要
相似文献
1
A commentary on 'Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: a meta-analysis'.对《中重度加重对慢性阻塞性肺疾病患者的健康相关生活质量、效用和肺功能有显著影响：一项荟萃分析》的述评
Int J Surg. 2024 Aug 1;110(8):5155-5156. doi: 10.1097/JS9.0000000000001448.
2
A commentary on 'Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: a meta-analysis'.对《中重度加重对慢性阻塞性肺疾病患者的健康相关生活质量、效用和肺功能有显著影响：一项荟萃分析》的述评
Int J Surg. 2024 Jan 1;110(1):580-581. doi: 10.1097/JS9.0000000000000763.
3
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).干预措施以提高慢性阻塞性肺疾病（COPD）药物治疗的依从性。
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.
4
Vitamin D for the management of chronic obstructive pulmonary disease.维生素D用于慢性阻塞性肺疾病的管理
Cochrane Database Syst Rev. 2024 Sep 27;9(9):CD013284. doi: 10.1002/14651858.CD013284.pub2.
5
Influence of Urinary Incontinence Related Factors on Health-Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.尿失禁相关因素对慢性阻塞性肺疾病患者健康相关生活质量的影响：一项横断面研究。
Int J Chron Obstruct Pulmon Dis. 2025 Jun 12;20:1881-1892. doi: 10.2147/COPD.S515494. eCollection 2025.
6
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
7
Glycopyrrolate/formoterol fumarate MDI in mild-to-moderate chronic obstructive pulmonary disease (PIONEER): a protocol for a randomised, double-blind, placebo-controlled trial.格隆溴铵/富马酸福莫特罗定量吸入气雾剂用于轻至中度慢性阻塞性肺疾病（先锋研究）：一项随机、双盲、安慰剂对照试验方案
BMJ Open Respir Res. 2025 Jun 15;12(1):e002656. doi: 10.1136/bmjresp-2024-002656.
8
Factors Influencing the Efficacy and Safety of Monoclonal Antibody Biologics in Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials.影响单克隆抗体生物制剂在慢性阻塞性肺疾病中疗效和安全性的因素：一项随机对照试验的荟萃分析
Lung. 2025 Mar 14;203(1):46. doi: 10.1007/s00408-025-00795-6.
9
Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.中重度慢性阻塞性肺疾病（COPD）患者的支持性自我管理：证据综合与经济分析
Health Technol Assess. 2015 May;19(36):1-516. doi: 10.3310/hta19360.
10
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预：针对慢性阻塞性肺疾病（COPD）患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
本文引用的文献
1
Tiotropium reduces clinically important deterioration in patients with mild-to-moderate chronic obstructive pulmonary disease: A post hoc analysis of the Tie-COPD study.噻托溴铵可减少轻中度慢性阻塞性肺疾病患者的临床重要恶化：Tie-COPD 研究的事后分析。
Respir Med. 2024 Feb;222:107527. doi: 10.1016/j.rmed.2024.107527. Epub 2024 Jan 8.
2
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement.临床重要恶化（CID）和 COPD 中的衰老：根据 PRISMA 声明进行的系统评价和荟萃回归分析。
Int J Chron Obstruct Pulmon Dis. 2023 Oct 10;18:2225-2243. doi: 10.2147/COPD.S396945. eCollection 2023.
3
One-year clinically important deterioration and long-term clinical course in Japanese patients with COPD: a multicenter observational cohort study.日本 COPD 患者的 1 年临床重要恶化和长期临床病程：一项多中心观察性队列研究。
BMC Pulm Med. 2021 May 12;21(1):159. doi: 10.1186/s12890-021-01510-w.
4
Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO Trials.噻托溴铵/奥达特罗与噻托溴铵单药治疗早期 COPD 患者的临床重要恶化的比较：TONADO 试验的事后分析。
Adv Ther. 2021 Jan;38(1):579-593. doi: 10.1007/s12325-020-01528-2. Epub 2020 Nov 11.
5
Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: A meta-analysis.中重度加重对慢性阻塞性肺疾病患者的健康相关生活质量、效用和肺功能有重大影响：一项荟萃分析。
Int J Surg. 2020 Jun;78:28-35. doi: 10.1016/j.ijsu.2020.04.010. Epub 2020 Apr 15.
Zotero 插件